HTP

Huobi Pool Launches Terra (LUNA) Staking for More Investors to Participate in its Ecosystem

Retrieved on: 
Friday, November 12, 2021
LUNA, Ecology, Ecosystem, HPT, ELA, BCH, Huobi, HTP, VIP, LTC, Investment, Growth, APR, Prisoner of war, POS, BTC, BSV, USDT, Mining, Farm, UST, ETH, Proof of stake, Terra, Cryptocurrency

LONDON, Nov. 12,2021 /PRNewswire/ -- Huobi Pool, the world's largest staking mining pool under Huobi Group, today announced the launch of Terra LUNA staking, offering investors a seamless way to vote for notes and earn rewards on the platform.

Key Points: 
  • LONDON, Nov. 12,2021 /PRNewswire/ -- Huobi Pool, the world's largest staking mining pool under Huobi Group, today announced the launch of Terra LUNA staking, offering investors a seamless way to vote for notes and earn rewards on the platform.
  • With the launch of the LUNA staking channel on Huobi Pool, token holders can participate and take advantage of node benefits, such as receiving profits from block generation.
  • In addition to LUNA, Huobi Pool has three new digital assets on its staking channel: XPRT, SOLANA and CSPR.
  • As a significant part of Huobi Group's ecosystem, Huobi Pool is mainly handling PoW mining and Staking mining.

HTG Molecular Diagnostics Reports Third Quarter 2021 Results

Retrieved on: 
Wednesday, November 10, 2021
RUO, Industry, Therapy, CEO, HTG, RNA, HTP, Growth, EAP, ISO, COVID-19, Research, Conference call, Sale, Conference, GLOBE, Drug discovery, Certification, Precision medicine, Nasdaq, EU, Medical device, Animal, Pharmaceutical industry, Lithium

TUCSON, Ariz., Nov. 10, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported its financial results for the quarter ended September 30, 2021.

Key Points: 
  • TUCSON, Ariz., Nov. 10, 2021 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, today reported its financial results for the quarter ended September 30, 2021.
  • Total revenue for the quarter ended September 30, 2021 increased by approximately 42% when compared to the same period in 2020.
  • Third Quarter 2021 Financial Highlights:
    Total revenue for the quarter ended September 30, 2021 was $2.5 million, compared with $1.8 million for the same period in 2020.
  • Net loss per share was $(0.60) for the quarter ended September 30, 2021 compared with $(1.12) for the third quarter of 2020.

CV Sciences, Inc. Announces Launch of PlusCBD™ Calm and Sleep Gummies

Retrieved on: 
Tuesday, May 11, 2021
Amino acids, Branches of biology, Amines, Hydroxyarenes, Dietary Supplements, Neurotransmitters, Anxiolytics, Theanine, 5-Hydroxytryptophan, Serotonin, Tryptophan, HTP

Studies have shown that 5-HTP (5-hydroxytryptophan) is a direct precursor for synthesis of the neurotransmitter serotonin, which may facilitate calm feelings and a positive mood.

Key Points: 
  • Studies have shown that 5-HTP (5-hydroxytryptophan) is a direct precursor for synthesis of the neurotransmitter serotonin, which may facilitate calm feelings and a positive mood.
  • L-Theanine is an amino acid found in green tea that has been extensively researched for stress management.
  • PlusCBD\xe2\x84\xa2 Calm and Sleep gummies contain no artificial flavoring or sweeteners, making them an attractive option for those looking to support their stress response and sleep cycle without artificial additives.
  • \xe2\x80\x9cOur Calm and Sleep gummies underscore the Company\xe2\x80\x99s ongoing commitment to advancing the CBD industry through science-backed formulations.\xe2\x80\x9d\nCV, or Curriculum Vitae, is Latin for \xe2\x80\x9ccourse of life\xe2\x80\x9d, and science is the pursuit of truth.

Evecxia Inc. Appoints Jacob Jacobsen, PhD, as Chief Scientific Officer

Retrieved on: 
Thursday, December 5, 2019
Biotechnology, Mental health, Health, Pharmaceutical, Clinical trials, Amino acids, Dietary Supplements, 5-Hydroxytryptophan, Hydroxyarenes, Nootropics, Tryptamines, HTP, Jacobsen, Tryptophan, Neuropsychiatry, Evecxia, EVX-101

Evecxia, Inc., a biopharmaceutical company focused on the treatment of neuropsychiatric diseases, today announced that it has appointed Jacob Jacobsen, PhD, as its Chief Scientific Officer (CSO).

Key Points: 
  • Evecxia, Inc., a biopharmaceutical company focused on the treatment of neuropsychiatric diseases, today announced that it has appointed Jacob Jacobsen, PhD, as its Chief Scientific Officer (CSO).
  • While at Duke University, Dr. Jacobsen built the 5-hydroxytryptophan slow-release (5-HTP SR) scientific and technical rationale undergirding EVX-101.
  • I am happy to be working with Jacob and we look forward to his contributions and welcome him to our dedicated and focused team.
  • For more information about the Evecxia and its product candidates, please visit www.evecxia.com or contact [email protected] .

Industry Consulting Service Joins the Belarus High Tech Park

Retrieved on: 
Tuesday, May 7, 2019
Technology, Software, Professional services, Consulting, Construction & Property, Commercial Building & Real Estate, HTP, Belarus High Technologies Park

We are proud to announce that Industry Consulting Service (ICS) has officially become a resident of the High Technology Park Belarus (HTP) , one of the leading IT clusters in Central and Eastern Europe.

Key Points: 
  • We are proud to announce that Industry Consulting Service (ICS) has officially become a resident of the High Technology Park Belarus (HTP) , one of the leading IT clusters in Central and Eastern Europe.
  • This year promises a continuation of that trend as ICS joins the successful network of IT companies in the HTP.
  • We hope that through this fruitful work as a resident of HTP, well provide you with even better service!
  • Industry Consulting Service is a Microsoft Certified Partner and an innovative provider of end-to-end ERP development and consulting services.